Flagship Harbor Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,747
Closed -$167K 814
2025
Q4
$167K Buy
+5,747
New +$172K 0.01% 718
2022
Q3
Sell
-6,379
Closed -$201K 588
2022
Q2
$201K Buy
6,379
+160
+3% +$5.59K 0.02% 564
2022
Q1
$286K Buy
+6,219
New +$296K 0.03% 497
2021
Q2
Sell
-6,182
Closed -$549K 636
2021
Q1
$549K Buy
6,182
+436
+8% +$43.2K 0.06% 321
2020
Q4
$536K Buy
5,746
+567
+11% +$45.2K 0.07% 289
2020
Q3
$330K Buy
5,179
+1,359
+36% +$79.6K 0.04% 341
2020
Q2
$199K Buy
3,820
+1,111
+41% +$47.7K 0.03% 461
2020
Q1
$85K Sell
2,709
-174
-6% -$5.81K 0.02% 594
2019
Q4
$97K Buy
2,883
+12
+0.4% +$381 0.02% 615
2019
Q3
$84K Sell
2,871
-200
-7% -$6.5K 0.02% 633
2019
Q2
$105K Buy
3,071
+100
+3% +$3.21K 0.02% 553
2019
Q1
$97K Buy
2,971
+471
+19% +$13.9K 0.02% 569
2018
Q4
$59K Buy
2,500
+2,100
+525% +$59.2K 0.01% 653
2018
Q3
$13K Buy
+400
New +$12.7K ﹤0.01% 1284

Other funds holding ARKG

Flagship Harbor Advisors's ARKG Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 5,747 shares — an estimated $167K sold.

Flagship Harbor Advisors first reported a position in ARKG in Q3 2018 and held it in 14 quarters. The position peaked at $549K in Q1 2021. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 5,747 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $167K.
  • Flagship Harbor Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 14 quarters.
  • Flagship Harbor Advisors's ARK Genomic Revolution ETF position peaked at $549K in Q1 2021.
  • 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.